[Cholesterin synthase inhibition and atherosclerosis].
Krone
W
W
Klinik II und Poliklinik für Innere Medizin, Universität zu Köln, 50924 Köln.
Faust
M
M
Kotzka
J
J
Müller-Wieland
D
D
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000517:prevention & control; D022762:CCAAT-Enhancer-Binding Proteins / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002784:Cholesterol / Q000096:biosynthesis; D008078:Cholesterol, LDL / Q000187:drug effects; D003066:Coenzyme A Ligases / Q000187:drug effects*; D004268:DNA-Binding Proteins / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006904:Hydroxymethylglutaryl-CoA Synthase; D006949:Hyperlipidemias / Q000188:drug therapy; D017035:Pravastatin / Q000494:pharmacology* / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors / Q000187:drug effects
D022762:CCAAT-Enhancer-Binding Proteins; D008078:Cholesterol, LDL; D004268:DNA-Binding Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors; D002784:Cholesterol; C086276:cerivastatin; D006904:Hydroxymethylglutaryl-CoA Synthase; D003066:Coenzyme A Ligases; D017035:Pravastatin